NIH-funded research U01 cooperative agreement

Integrated delivery of cancer care for young people living with HIV in Zambia

Official title: Integrated delivery of cancer control interventions for adolescents and young adults living with HIV in Zambia

Funded at Implenomics Llcs · NIH-11535318 · Data updated 2026-11-12

A new program aims to help adolescents and young adults with HIV in Zambia get earlier cancer detection and better care by testing a practical tool that plans and scales up cancer-control services.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionImplenomics Llcs
NIH-funded
Lab location1 site (Marblehead, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2027
Funding year2026
Award (this year)$105,300
NIH project number3U01CA275054-05S1
Project IDNIH-11535318 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adolescents and young adults living with HIV in participating Zambian clinics who are eligible for integrated cancer-detection and HIV-care services.

Less likely to help

Patients in settings without access to the participating clinics or with different care pathways may not directly benefit.

What this research studies

This project builds on an established model that blends cancer screening and HIV care in clinics, and it will pilot a SCORE tool to map what resources and steps are needed to scale up successful cancer-control strategies. It uses real-world HIV clinics in Zambia to test how readiness and capacity can be strengthened, with a focus on early cancer diagnosis through the ARROW program. The work includes gathering data on resources, workflows, and costs to guide future implementation at scale. By tying together cancer detection, HIV care, and system resources, the study aims to make cancer care more accessible for AYAHIV in high-need settings.

Why it matters

Potential benefit: If successful, the project could improve early cancer detection and integrated care for adolescents and young adults with HIV, reducing cancer-related morbidity and mortality.

How similar studies have gone: Previous work showing benefits of integrated cancer-HIV care and implementation tooling supports the approach, though SCORE is a novel tool in this context.

Where this research is happening

  • Implenomics Llcs
    Marblehead, United States
    Active

Researchers

  • Principal investigator: Subramanian, Sujha — Implenomics Llcs
  • Study coordinator: Subramanian, Sujha

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.